CareMax, Inc.

Greetings and welcome to the CareMax second quarter 2021 financial results conference call. At this time, all participants are in a listen-only mode. A question and answer session will follow the formal presentation. If anyone should require operator assistance during the conference, please press star zero on your telephone keypad. As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Devin Sullivan, Senior Vice President of the Equity Group. Thank you. You may begin.

Thank you, Jesse. Good morning, and thank you for joining us for CareMax second quarter earnings call. During the call, we will be discussing certain forward-looking information. These forward-looking statements are based on assumptions and assessments made by CareMax's management in light of their experience and assessment of historical trends, current conditions, expected future developments, and other factors they believe to be appropriate. Any forward-looking statements made during this call are made as of today. and CareMax undertakes no duty to update or revise any such statements, whether as a result of new information, future events, or otherwise. Important factors that could cause actual results, developments, and business decisions to differ materially from forward-looking statements are described in the company's filings with the SEC, including the sections entitled risk factors. In today's remarks by management, we will be discussing non-GAAP financial metrics, a reconciliation of these non-GAAP financial measures to the most comparable GAAP measures can be found in this morning's earnings press release. With that said, I'd now like to turn the call over to Richard Barish, Executive Chairman of CareMax. Richard, please go ahead.

Thanks, Devin. Hi, everyone. Thanks for joining us this morning for the first quarterly conference call for CareMax. CareMax IMC and our team at Deerfield began this journey approximately a year ago and started talking to potential investors last fall. It's useful to look back at what we planned for the company and what has been accomplished. It's also useful to recognize what we need to do to fulfill the promise of the company. Our thesis was built around the success that CareMax 1.0 had achieved as an entrepreneurial company that was created from the ground up. Carlos and his team, using proprietary software and processes, became quite successful in the ultra-competitive South Florida market. with a care model to work to deliver better care to patients while generating favorable financial outcomes. Our thesis was that success in a competitive Florida market was a key proof point that we could expand this technology-forward model locally, regionally, and nationally. The first significant building block was the addition of IMC, an in-market company that brought immediate scale to our Medicare business and added profitable non-Medicare lives. A significant part of the plan was and still is to integrate the companies and improve the results of IMC to achieve results similar to CareMax 1.0. Although delayed by the lengthy proxy process, this work is well underway and we're benefiting from the talent that both organizations have brought to this newly combined companies. In addition, as Carlos will describe, we are supplementing our team with the additional talent we need to manage the growth that we have planned. The second part of the thesis was that we can achieve organic growth from the space of 26 centers, including Tuckins who are on track to handily exceed the 15% organic growth metric that we set forth. In addition, based on a robust pipeline that came from both CareMax 1.0 and IMC sites, We believe that with the capital we raised in the GoPublic, we could augment our organic growth with selective M&A. The closed transaction of SMA shortly after the D-SPAC and the anticipated closing of our acquisition of DNF proves out this part of the thesis. Both acquisitions are accretive, and each brings significant strategic and geographic benefits. Importantly, DNF accelerates our expansion outside of South Florida. In the aggregate, we are on target to finish 2001 with approximately double the MA membership that we had when we closed the transaction in June. Turning to current operations, we were not immune from the industry and countrywide COVID pressures. The team will elaborate, but we see these impacts as temporary and we remain confident in the underlying thesis that led to this investment. We have more work to do over the next four to five months, but we believe we are on path to meet our 2021 membership and revenue goals. And assuming that we put COVID behind us, we're confident that we will enter 2022 with the building blocks to achieve expected organic growth and profitability in our core markets. Lastly, and most important, we're very excited about the emerging opportunities that have emerged as a result of the platform that Care Max has built. Carlos would describe in more detail our ambitious plans to expand our reach nationally and through our relationship, our new relationship with Related, and as well as our newly expanded relationship with Anthem. And now I'd like to turn it over to Carlos for more detail on our performance year to date and the growth opportunities that lie in the balance of the year and in the future. Carlos?